ACS Publications. Most Trusted. Most Cited. Most Read
Synthesis and Ligand Binding of Nortropane Derivatives:  N-Substituted 2β-Carbomethoxy-3β-(4‘-iodophenyl)nortropane and N-(3-Iodoprop-(2E)-enyl)-2β-carbomethoxy-3β-(3‘,4‘-disubstituted phenyl)nortropane. New High-Affinity and Selective Compounds for the Dopamine Transporter

OR SEARCH CITATIONS

My Activity
Publications

Figure 1Loading Img
Download Hi-Res ImageDownload to MS-PowerPointCite This:J. Med. Chem. 1997, 40, 9, 1366-1372
    Article

    Synthesis and Ligand Binding of Nortropane Derivatives:  N-Substituted 2β-Carbomethoxy-3β-(4‘-iodophenyl)nortropane and N-(3-Iodoprop-(2E)-enyl)-2β-carbomethoxy-3β-(3‘,4‘-disubstituted phenyl)nortropane. New High-Affinity and Selective Compounds for the Dopamine Transporter
    Click to copy article linkArticle link copied!

    View Author Information
    INSERM U316, Laboratoire de Biophysique Médicale et Pharmaceutique, 31 avenue Monge, 37200 Tours, France
    Other Access Options

    Journal of Medicinal Chemistry

    Cite this: J. Med. Chem. 1997, 40, 9, 1366–1372
    Click to copy citationCitation copied!
    https://doi.org/10.1021/jm960795d
    Published April 25, 1997
    Copyright © 1997 American Chemical Society
    Request reuse permissions

    Abstract

    Click to copy section linkSection link copied!

    Two novel series of iodinated N-substituted analogs of 2β-carbomethoxy-3β-(4‘-iodophenyl)tropane (β-CIT) and N-(3-iodoprop-(2E)-enyl)-2β-carbomethoxy-3β-(3‘,4‘-disubstituted phenyl)nortropane were synthesized. They were evaluated for their inhibitory properties on dopamine (DAT), serotonin (5-HTT), and norepinephrine (NET) transporters in rat brain homogenates using [3H]GBR-12935, [3H]paroxetine, and [3H]nisoxetine as specific ligands. All new N-substituted analogs of β-CIT exhibited higher DAT selectivity over both 5-HTT and NET than β-CIT. Moreover compounds with the N-substituents propynyl (6), crotyl (4), 2-bromoprop-(2E)-enyl (5), and 3-iodoprop-(2E)-enyl (3d) showed similar to higher DAT affinities than β-CIT (respectively 14, 15, 30, and 30 nM vs 27 nM). Compound 3d was found to be the most selective DAT agent of this series (5-HTT/DAT = 32.0 vs 0.1 for β-CIT). The N-(3-iodoprop-(2E)-enyl) chain linked to the tropane nitrogen was therefore maintained on the tropane structure, and phenyl substitution was carried out in order to improve DAT affinity. Ki values of N-(3-iodoprop-(2E)-enyl)-2β-carbomethoxy-3β-(3‘,4‘-disubstituted phenyl)nortropanes revealed that phenyl, 4‘-isopropyl, and 4‘-n-propyl derivatives weakly inhibited specific binding to DAT, whereas phenyl substitution with 4‘-methyl (3c), 3‘,4‘-dichloro (3b), and 4‘-iodo (3d) yielded high-DAT reuptake agents with increased DAT selectivity compared to β-CIT. These results demonstrate that the combination of a nitrogen and a phenyl substitution yields compounds with high affinity and selectivity for the dopamine transporter which are usable as SPECT markers for DA neurons.

    Copyright © 1997 American Chemical Society

    Subjects

    what are subjects

    Read this article

    To access this article, please review the available access options below.

    Get instant access

    Purchase Access

    Read this article for 48 hours. Check out below using your ACS ID or as a guest.

    Recommended

    Access through Your Institution

    You may have access to this article through your institution.

    Your institution does not have access to this content. Add or change your institution or let them know you’d like them to include access.

    †

     Cis-Bio Industrie, 91192 Gif-sur-Yvette, France.

    *

    In papers with more than one author, the asterisk indicates the name of the author to whom inquiries about the paper should be addressed.

    ✗

     Abstract published in Advance ACS Abstracts, March 15, 1997.

    Cited By

    Click to copy section linkSection link copied!
    Citation Statements
    Explore this article's citation statements on scite.ai
    powered by  Scite

    This article is cited by 112 publications.

    1. Siim Kukk, Olavi Loog, Jukka-Veli Hiltunen, Jaak Järv. In Vitro Ligand Binding Kinetics Explains the Pharmacokinetics of [18F]FE-PE2I in Dopamine Transporter PET Imaging. ACS Medicinal Chemistry Letters 2018, 9 (12) , 1292-1296. https://doi.org/10.1021/acsmedchemlett.8b00504
    2. Satendra Singh. Chemistry, Design, and Structure−Activity Relationship of Cocaine Antagonists. Chemical Reviews 2000, 100 (3) , 925-1024. https://doi.org/10.1021/cr9700538
    3. Praveen Honhar, Faranak Ebrahimian Sadabad, Sule Tinaz, Jean-Dominique Gallezot, Mark Dias, Mika Naganawa, Yanghong Yang, Shannan Henry, Ansel T Hillmer, Hong Gao, Soheila Najafzadeh, Robert Comley, Nabeel Nabulsi, Yiyun Huang, Sjoerd J Finnema, Richard E Carson, David Matuskey. Clinical correlates of dopamine transporter availability in cross-sectional and longitudinal studies with [18F]FE-PE2I PET: independent validation with new insights. Brain Communications 2024, 6 (5) https://doi.org/10.1093/braincomms/fcae345
    4. My Jonasson, Andreas Frick, Patrik Fazio, Olof Hjorth, Torsten Danfors, Jan Axelsson, Lieuwe Appel, Tomas Furmark, Andrea Varrone, Mark Lubberink. Striatal dopamine transporter and receptor availability correlate with relative cerebral blood flow measured with [ 11 C]PE2I, [ 18 F]FE-PE2I and [ 11 C]raclopride PET in healthy individuals. Journal of Cerebral Blood Flow & Metabolism 2023, 43 (7) , 1206-1215. https://doi.org/10.1177/0271678X231160881
    5. Sara af Bjerkén, Jan Axelsson, Anne Larsson, Carolina Flygare, Jussi Remes, Sara Strandberg, Linda Eriksson, David Bäckström, Susanna Jakobson Mo. Reliability and validity of visual analysis of [18F]FE-PE2I PET/CT in early Parkinsonian disease. Nuclear Medicine Communications 2023, 44 (5) , 397-406. https://doi.org/10.1097/MNM.0000000000001679
    6. Heather Wilson, Edoardo Rosario de Natale, Marios Politis. Recent Advances in Neuroimaging Techniques to Assist Clinical Trials on Cell-Based Therapies in Neurodegenerative Diseases. Stem Cells 2022, 40 (8) , 724-735. https://doi.org/10.1093/stmcls/sxac039
    7. Nicolas ARLICOT, Johnny VERCOUILLIE, Cécile MALHERBE, Rudy BIDAULT, Valérie GISSOT, Serge MAIA, Laurent BARANTIN, Jean-Philippe COTTIER, Jean-Bernard DELOYE, Denis GUILLOTEAU, Maria-Joao RIBEIRO. Imaging of dopamine transporter with [18F]LBT-999: initial evaluation in healthy volunteers. The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2022, 66 (2) https://doi.org/10.23736/S1824-4785.19.03175-3
    8. Tsuyoshi Nogami, Ryosuke Arakawa, Takeshi Sakayori, Yumiko Ikeda, Yoshiro Okubo, Amane Tateno. Effect of DL-Methylephedrine on Dopamine Transporter Using Positron Emission Tomography With [18F]FE-PE2I. Frontiers in Psychiatry 2022, 13 https://doi.org/10.3389/fpsyt.2022.799319
    9. Susanna Jakobson Mo, Jan Axelsson, Lars J Stiernman, Anne Larsson, Sara af Bjerkén, David Bäckström, Therese Gabrielsson Kellgren, Andrea Varrone, Katrine Riklund. VNTR polymorphism in the SLC6A3 gene does not influence dopamine transporter availability measured by [18F]FE-PE2I PET or [123I]FP-Cit SPECT. Nuclear Medicine Communications 2022, 43 (3) , 247-255. https://doi.org/10.1097/MNM.0000000000001514
    10. Hiroki Moriya, Mikael Tiger, Amane Tateno, Takeshi Sakayori, Takahiro Masuoka, WooChan Kim, Ryosuke Arakawa, Yoshiro Okubo. Low dopamine transporter binding in the nucleus accumbens in geriatric patients with severe depression. Psychiatry and Clinical Neurosciences 2020, 74 (8) , 424-430. https://doi.org/10.1111/pcn.13020
    11. Marie Beaurain, Anne-Sophie Salabert, Maria Joao Ribeiro, Nicolas Arlicot, Philippe Damier, Florence Le Jeune, Jean-François Demonet, Pierre Payoux. Innovative Molecular Imaging for Clinical Research, Therapeutic Stratification, and Nosography in Neuroscience. Frontiers in Medicine 2019, 6 https://doi.org/10.3389/fmed.2019.00268
    12. Takayuki Ose, Joonas A. Autio, Masahiro Ohno, Kantaro Nishigori, Nobuyoshi Tanki, Ami Igesaka, Tomoko Mori, Hisashi Doi, Yasuhiro Wada, Iwao Nakajima, Hiroshi Watabe, Takuya Hayashi. A novel Tungsten-based fiducial marker for multi-modal brain imaging. Journal of Neuroscience Methods 2019, 323 , 22-31. https://doi.org/10.1016/j.jneumeth.2019.04.014
    13. Antonio Martín-Bastida, Nicholas P Lao-Kaim, Andreas Antonios Roussakis, Graham E Searle, Yue Xing, Roger N Gunn, Stefan T Schwarz, Roger A Barker, Dorothee P Auer, Paola Piccini. Relationship between neuromelanin and dopamine terminals within the Parkinson’s nigrostriatal system. Brain 2019, 142 (7) , 2023-2036. https://doi.org/10.1093/brain/awz120
    14. Sylvie Chalon, Johnny Vercouillie, Pierre Payoux, Jean-Bernard Deloye, Cécile Malherbe, Florence Le Jeune, Nicolas Arlicot, Anne-Sophie Salabert, Denis Guilloteau, Patrick Emond, Maria-Joao Ribeiro. The Story of the Dopamine Transporter PET Tracer LBT-999: From Conception to Clinical Use. Frontiers in Medicine 2019, 6 https://doi.org/10.3389/fmed.2019.00090
    15. Susanna Jakobson Mo, Jan Axelsson, Lars Jonasson, Anne Larsson, Mattias J. Ögren, Margareta Ögren, Andrea Varrone, Linda Eriksson, David Bäckström, Sara af Bjerkén, Jan Linder, Katrine Riklund. Dopamine transporter imaging with [18F]FE-PE2I PET and [123I]FP-CIT SPECT—a clinical comparison. EJNMMI Research 2018, 8 (1) https://doi.org/10.1186/s13550-018-0450-0
    16. Christopher T. Smith, M. Danica San Juan, Linh C. Dang, Daniel T. Katz, Scott F. Perkins, Leah L. Burgess, Ronald L. Cowan, H. Charles Manning, Michael L. Nickels, Daniel O. Claassen, Gregory R. Samanez-Larkin, David H. Zald. Ventral striatal dopamine transporter availability is associated with lower trait motor impulsivity in healthy adults. Translational Psychiatry 2018, 8 (1) https://doi.org/10.1038/s41398-018-0328-y
    17. Siim Kukk, Jaak Järv. Small Structural Changes at the N ‐position of the Tropane Core Control the Mechanism of Nortropane Derivatives Binding to Dopamine Transporter. ChemistrySelect 2018, 3 (23) , 6581-6584. https://doi.org/10.1002/slct.201801532
    18. Edoardo R. de Natale, Flavia Niccolini, Heather Wilson, Marios Politis. Molecular Imaging of the Dopaminergic System in Idiopathic Parkinson's Disease. 2018, 131-172. https://doi.org/10.1016/bs.irn.2018.08.003
    19. Weihua Li, Nick P. Lao‐Kaim, Andreas A. Roussakis, Antonio Martín‐Bastida, Natalie Valle‐Guzman, Gesine Paul, Clare Loane, Håkan Widner, Marios Politis, Tom Foltynie, Roger A. Barker, Paola Piccini. 11 C‐PE2I and 18 F‐Dopa PET for assessing progression rate in Parkinson's: A longitudinal study. Movement Disorders 2018, 33 (1) , 117-127. https://doi.org/10.1002/mds.27183
    20. Siim Kukk, Vladimir Stepanov, Jaak Järv. Thermal Stability of Dopamine Transporters. The Journal of Membrane Biology 2015, 248 (4) , 775-781. https://doi.org/10.1007/s00232-015-9794-9
    21. Ming Zheng, Lieuwe Appel, Feng Luo, Roger Lane, David Burt, Robert Risinger, Gunnar Antoni, Matthew Cahir, Sanjay Keswani, Wendy Hayes, Zubin Bhagwagar. Safety, pharmacokinetic, and positron emission tomography evaluation of serotonin and dopamine transporter occupancy following multiple-dose administration of the triple monoamine reuptake inhibitor BMS-820836. Psychopharmacology 2015, 232 (3) , 529-540. https://doi.org/10.1007/s00213-014-3688-x
    22. Lieuwe Appel, My Jonasson, Torsten Danfors, Dag Nyholm, Håkan Askmark, Mark Lubberink, Jens Sörensen. Use of 11 C-PE2I PET in Differential Diagnosis of Parkinsonian Disorders. Journal of Nuclear Medicine 2015, 56 (2) , 234-242. https://doi.org/10.2967/jnumed.114.148619
    23. Julien Vezoli, Kwamivi Dzahini, Nicolas Costes, Charles R.E. Wilson, Karim Fifel, Howard M. Cooper, Henry Kennedy, Emmanuel Procyk. Increased DAT binding in the early stage of the dopaminergic lesion: A longitudinal [11C]PE2I binding study in the MPTP-monkey. NeuroImage 2014, 102 , 249-261. https://doi.org/10.1016/j.neuroimage.2014.07.059
    24. WooChan Kim, Amane Tateno, Ryosuke Arakawa, Takeshi Sakayori, Yumiko Ikeda, Hidenori Suzuki, Yoshiro Okubo. In vivo activity of modafinil on dopamine transporter measured with positron emission tomography and [18F]FE-PE2I. The International Journal of Neuropsychopharmacology 2014, 17 (05) , 697-703. https://doi.org/10.1017/S1461145713001612
    25. Yoshitoshi Shingai, Amane Tateno, Ryosuke Arakawa, Takeshi Sakayori, WooChan Kim, Hidenori Suzuki, Yoshiro Okubo. Age-related decline in dopamine transporter in human brain using PET with a new radioligand [18F]FE-PE2I. Annals of Nuclear Medicine 2014, 28 (3) , 220-226. https://doi.org/10.1007/s12149-013-0798-1
    26. Karim Fifel, Julien Vezoli, Kwamivi Dzahini, Bruno Claustrat, Vincent Leviel, Henry Kennedy, Emmanuel Procyk, Ouria Dkhissi-Benyahya, Claude Gronfier, Howard M. Cooper, . Alteration of Daily and Circadian Rhythms following Dopamine Depletion in MPTP Treated Non-Human Primates. PLoS ONE 2014, 9 (1) , e86240. https://doi.org/10.1371/journal.pone.0086240
    27. P. J. Riss, K. Stockhofe, F. Roesch. Tropane‐derived 11 C‐labelled and 18 F‐labelled DAT ligands. Journal of Labelled Compounds and Radiopharmaceuticals 2013, 56 (3-4) , 149-158. https://doi.org/10.1002/jlcr.3018
    28. Takeshi Sasaki, Hiroshi Ito, Yasuyuki Kimura, Ryosuke Arakawa, Harumasa Takano, Chie Seki, Fumitoshi Kodaka, Saori Fujie, Keisuke Takahata, Tsuyoshi Nogami, Masayuki Suzuki, Hironobu Fujiwara, Hidehiko Takahashi, Ryuji Nakao, Toshimitsu Fukumura, Andrea Varrone, Christer Halldin, Toru Nishikawa, Tetsuya Suhara. Quantification of Dopamine Transporter in Human Brain Using PET with 18 F-FE-PE2I. Journal of Nuclear Medicine 2012, 53 (7) , 1065-1073. https://doi.org/10.2967/jnumed.111.101626
    29. Marie-Anne Peyronneau, Wadad Saba, Frédéric Dollé, Sébastien Goutal, Christine Coulon, Michel Bottlaender, Héric Valette. Difficulties in dopamine transporter radioligand PET analysis: the example of LBT-999 using [18F] and [11C] labelling. Nuclear Medicine and Biology 2012, 39 (3) , 347-359. https://doi.org/10.1016/j.nucmedbio.2011.09.006
    30. Morten Ziebell, Birgitte B. Andersen, Gerda Thomsen, Lars H. Pinborg, Merete Karlsborg, Steen G. Hasselbalch, Gitte M. Knudsen. Predictive value of dopamine transporter SPECT imaging with [123I]PE2I in patients with subtle parkinsonian symptoms. European Journal of Nuclear Medicine and Molecular Imaging 2012, 39 (2) , 242-250. https://doi.org/10.1007/s00259-011-1976-9
    31. Sylvie Mavel, Zoya Mincheva, Nathalie Méheux, Yvan Carcenac, Denis Guilloteau, Mohamed Abarbri, Patrick Emond. QSAR study and synthesis of new phenyltropanes as ligands of the dopamine transporter (DAT). Bioorganic & Medicinal Chemistry 2012, 20 (4) , 1388-1395. https://doi.org/10.1016/j.bmc.2012.01.014
    32. Ikuo Odano, Andrea Varrone, Ivanka Savic, Carolina Ciumas, Per Karlsson, Aurelija Jucaite, Christer Halldin, Lars Farde. Quantitative PET analyses of regional [11C]PE2I binding to the dopamine transporter — Application to juvenile myoclonic epilepsy. NeuroImage 2012, 59 (4) , 3582-3593. https://doi.org/10.1016/j.neuroimage.2011.10.067
    33. Habib Zaidi, Miho Shidahara. Neuroreceptor Imaging. 2012, 305-329. https://doi.org/10.1007/978-1-4614-1788-0_11
    34. Nicolas Tournier, Héric Valette, Marie-Anne Peyronneau, Wadad Saba, Sébastien Goutal, Bertrand Kuhnast, Frédéric Dollé, Jean-Michel Scherrmann, Salvatore Cisternino, Michel Bottlaender. Transport of Selected PET Radiotracers by Human P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2): An In Vitro Screening. Journal of Nuclear Medicine 2011, 52 (3) , 415-423. https://doi.org/10.2967/jnumed.110.079608
    35. Samuel D. Banister, Iman A. Moussa, Corinne Beinat, Aaron J. Reynolds, Paolo Schiavini, William T. Jorgensen, Michael Kassiou. Trishomocubane as a scaffold for the development of selective dopamine transporter (DAT) ligands. Bioorganic & Medicinal Chemistry Letters 2011, 21 (1) , 38-41. https://doi.org/10.1016/j.bmcl.2010.11.075
    36. Morten Ziebell, Signe Holm-Hansen, Gerda Thomsen, Aase Wagner, Peter Jensen, Lars H. Pinborg, Gitte Moos Knudsen. Serotonin Transporters in Dopamine Transporter Imaging: A Head-to-Head Comparison of Dopamine Transporter SPECT Radioligands 123 I-FP-CIT and 123 I-PE2I. Journal of Nuclear Medicine 2010, 51 (12) , 1885-1891. https://doi.org/10.2967/jnumed.110.078337
    37. Päivi Marjamäki, Merja Haaparanta, Sarita Forsback, Veronica Fagerholm, Olli Eskola, Tove Grönroos, Teija Koivula, Olof Solin. Comparison of 2β-Carbomethoxy-3β-(4-[18F]Fluorophenyl)Tropane and N-(3-[18F]Fluoropropyl)-2β-Carbomethoxy-3β-(4-Fluorophenyl)Nortropane, Tracers for Imaging Dopamine Transporter in Rat. Molecular Imaging and Biology 2010, 12 (3) , 269-277. https://doi.org/10.1007/s11307-009-0278-0
    38. Chie Seki, Hiroshi Ito, Tetsuya Ichimiya, Ryosuke Arakawa, Yoko Ikoma, Miho Shidahara, Jun Maeda, Akihiro Takano, Hidehiko Takahashi, Yuichi Kimura, Kazutoshi Suzuki, Iwao Kanno, Tetsuya Suhara. Quantitative analysis of dopamine transporters in human brain using [11C]PE2I and positron emission tomography: evaluation of reference tissue models. Annals of Nuclear Medicine 2010, 24 (4) , 249-260. https://doi.org/10.1007/s12149-010-0364-z
    39. Patrick J. Riss, Fabian Debus, René Hummerich, Ulrich Schmidt, Patrick Schloss, Hartmut Lueddens, Frank Roesch. Ex vivo and in vivo Evaluation of [ 18 F]PR04.MZ in Rodents: A Selective Dopamine Transporter Imaging Agent. ChemMedChem 2009, 4 (9) , 1480-1487. https://doi.org/10.1002/cmdc.200900177
    40. Magnus Schou, Carsten Steiger, Andrea Varrone, Denis Guilloteau, Christer Halldin. Synthesis, radiolabeling and preliminary in vivo evaluation of [18F]FE-PE2I, a new probe for the dopamine transporter. Bioorganic & Medicinal Chemistry Letters 2009, 19 (16) , 4843-4845. https://doi.org/10.1016/j.bmcl.2009.06.032
    41. S. De Bruyne, T. L. Boos, L. wyffels, J. L. Goeman, K. C. Rice, F. De Vos. Synthesis, radiosynthesis and in vivo evaluation of [ 123 I]‐4‐(2‐(bis(4‐fluorophenyl)methoxy)ethyl)‐1‐(4‐iodobenzyl)piperidine as a selective tracer for imaging the dopamine transporter. Journal of Labelled Compounds and Radiopharmaceuticals 2009, 52 (8) , 304-311. https://doi.org/10.1002/jlcr.1603
    42. Patrick Johannes Riss, René Hummerich, Patrick Schloss. Synthesis and monoamine uptake inhibition of conformationally constrained 2β-carbomethoxy-3β-phenyl tropanes. Organic & Biomolecular Chemistry 2009, 7 (13) , 2688. https://doi.org/10.1039/b902863c
    43. Vladimir Stepanov, Jaak Järv. Kinetic mechanism of dopamine transporter interaction with 1-(2-(bis-(4-fluorophenyl)methoxy)ethyl)-4-(3-phenylpropyl)piperazine (GBR 12909). Neurochemistry International 2008, 53 (6-8) , 370-373. https://doi.org/10.1016/j.neuint.2008.09.005
    44. Jeffrey H. Meyer. Applying Neuroimaging Ligands to Study Major Depressive Disorder. Seminars in Nuclear Medicine 2008, 38 (4) , 287-304. https://doi.org/10.1053/j.semnuclmed.2008.02.007
    45. Jussi Hirvonen, Jarkko Johansson, Mika Teräs, Vesa Oikonen, Ville Lumme, Pauliina Virsu, Anne Roivainen, Kjell Någren, Christer Halldin, Lars Farde, Jarmo Hietala. Measurement of Striatal and Extrastriatal Dopamine Transporter Binding with High-Resolution PET and [ 11 C]PE2I: Quantitative Modeling and Test—Retest Reproducibility. Journal of Cerebral Blood Flow & Metabolism 2008, 28 (5) , 1059-1069. https://doi.org/10.1038/sj.jcbfm.9600607
    46. Patrick Emond, Denis Guilloteau, Sylvie Chalon. PE2I: A Radiopharmaceutical for In vivo Exploration of the Dopamine Transporter. CNS Neuroscience & Therapeutics 2008, 14 (1) , 47-64. https://doi.org/10.1111/j.1755-5949.2007.00033.x
    47. Patrick Emond, Denis Guilloteau, Sylvie Chalon. PE2I: A Radiopharmaceutical for In vivo Exploration of the Dopamine Transporter. CNS Neuroscience & Therapeutics 2008, 14 (1) , 47-64. https://doi.org/10.1111/j.1527-3458.2007.00033.x
    48. Teija Koivula, Päivi Marjamäki, Merja Haaparanta, Veronica Fagerholm, Tove Grönroos, Tiina Lipponen, Outi Perhola, Jouko Vepsäläinen, Olof Solin. Ex vivo evaluation of N-(3-[18F]fluoropropyl)-2β-carbomethoxy-3β-(4-fluorophenyl)nortropane in rats. Nuclear Medicine and Biology 2008, 35 (2) , 177-183. https://doi.org/10.1016/j.nucmedbio.2007.09.006
    49. Dirk Roeda, Bertrand Kuhnast, Akli Hammadi, Frédéric Dollé. The Service Hospitalier Frédéric Joliot – contributions to PET chemistry over the years. Journal of Labelled Compounds and Radiopharmaceuticals 2007, 50 (9-10) , 848-866. https://doi.org/10.1002/jlcr.1420
    50. Birte Drewes, Wiebke Sihver, Sabine Willbold, Ray A. Olsson, Heinz H. Coenen. New 2α-tropane amides as potential PET ligands for the dopamine transporter. Nuclear Medicine and Biology 2007, 34 (5) , 531-539. https://doi.org/10.1016/j.nucmedbio.2007.04.007
    51. Frédéric Dollé, Julie Helfenbein, Françoise Hinnen, Sylvie Mavel, Zoïa Mincheva, Wadad Saba, Marie‐Anne Schöllhorn‐Peyronneau, Heric Valette, Lucette Garreau, Sylvie Chalon, Christer Halldin, Jean‐Claude Madelmont, Jean‐Bernard Deloye, Michel Bottlaender, Joël Le Gailliard, Denis Guilloteau, Patrick Emond. One‐step radiosynthesis of [ 18 F]LBT‐999: a selective radioligand for the visualization of the dopamine transporter with PET. Journal of Labelled Compounds and Radiopharmaceuticals 2007, 50 (8) , 716-723. https://doi.org/10.1002/jlcr.1412
    52. H. Umesha Shetty, Sami S. Zoghbi, Jeih-San Liow, Masanori Ichise, Jinsoo Hong, John L. Musachio, Christer Halldin, Jurgen Seidel, Robert B. Innis, Victor W. Pike. Identification and regional distribution in rat brain of radiometabolites of the dopamine transporter PET radioligand [11C]PE2I. European Journal of Nuclear Medicine and Molecular Imaging 2007, 34 (5) , 667-678. https://doi.org/10.1007/s00259-006-0277-1
    53. Maria-João Ribeiro, Marcel Ricard, Marie-Angele Lièvre, Sandrine Bourgeois, Patrick Emond, Philippe Gervais, Frédéric Dollé, André Syrota. Whole-body distribution and radiation dosimetry of the dopamine transporter radioligand [11C]PE2I in healthy volunteers. Nuclear Medicine and Biology 2007, 34 (4) , 465-470. https://doi.org/10.1016/j.nucmedbio.2007.02.005
    54. Vladimir Stepanov, Magnus Schou, Jaak Järv, Christer Halldin. Synthesis of 3H-labeled N-(3-iodoprop-2E-enyl)-2β-carbomethoxy-3β-(4-methylphenyl)nortropane (PE2I) and its interaction with mice striatal membrane fragments. Applied Radiation and Isotopes 2007, 65 (3) , 293-300. https://doi.org/10.1016/j.apradiso.2006.09.003
    55. W. Sihver, B. Drewes, A. Schulze, R.A. Olsson, H.H. Coenen. Evaluation of novel tropane analogues in comparison with the binding characteristics of [18F]FP-CIT and [131I]β-CIT. Nuclear Medicine and Biology 2007, 34 (2) , 211-219. https://doi.org/10.1016/j.nucmedbio.2006.11.005
    56. Françoise Riché, Fadi Masri, Monique Lopez. Diastereoselective synthesis of polyfunctionalized piperidines as precursors of dopamine transporter imaging agents. Tetrahedron Letters 2007, 48 (9) , 1609-1612. https://doi.org/10.1016/j.tetlet.2006.12.141
    57. Morten Ziebell, Gerda Thomsen, Gitte M. Knudsen, Robin de Nijs, Claus Svarer, Aase Wagner, Lars H. Pinborg. Reproducibility of [123I]PE2I binding to dopamine transporters with SPECT. European Journal of Nuclear Medicine and Molecular Imaging 2007, 34 (1) , 101-109. https://doi.org/10.1007/s00259-006-0161-z
    58. Wadad Saba, Héric Valette, Marie‐Anne Schöllhorn‐Peyronneau, Christine Coulon, Michele Ottaviani, Sylvie Chalon, Frédéric Dolle, Patrick Emond, Christer Halldin, Julie Helfenbein, Jean‐Claude Madelmont, Jean‐Bernard Deloye, Denis Guilloteau, Michel Bottlaender. [ 11 C]LBT‐999: A suitable radioligand for investigation of extra‐striatal dopamine transporter with PET. Synapse 2007, 61 (1) , 17-23. https://doi.org/10.1002/syn.20337
    59. Erkki Tupala, Pirjo Halonen, Jari Tiihonen. Visualization of the cortical dopamine transporter in type 1 and 2 alcoholics with human whole hemisphere autoradiography. European Neuropsychopharmacology 2006, 16 (8) , 552-560. https://doi.org/10.1016/j.euroneuro.2006.02.008
    60. Vladimir Stepanov, Jaak Järv. Slow isomerization step in the interaction between mouse dopamine transporter and dopamine re-uptake inhibitor N-(3-iodoprop-2E-enyl)-2β-carbo-[3H]methoxy-3β-(4′-methylphenyl)nortropane. Neuroscience Letters 2006, 410 (3) , 218-221. https://doi.org/10.1016/j.neulet.2006.10.007
    61. Frédéric Dollé, Françoise Hinnen, Patrick Emond, Sylvie Mavel, Zoïa Mincheva, Wadad Saba, Marie-Anne Schöllhorn-Peyronneau, Heric Valette, Lucette Garreau, Sylvie Chalon, Christer Halldin, Julie Helfenbein, Joël Legaillard, Jean-Claude Madelmont, Jean-Bernard Deloye, Michel Bottlaender, Denis Guilloteau. Radiosynthesis of [18F]LBT-999, a selective radioligand for the visualization of the dopamine transporter with PET. Journal of Labelled Compounds and Radiopharmaceuticals 2006, 49 (8) , 687-698. https://doi.org/10.1002/jlcr.1092
    62. Aurelija Jucaite, Ikuo Odano, Hans Olsson, Stefan Pauli, Christer Halldin, Lars Farde. Quantitative analyses of regional [11C]PE2I binding to the dopamine transporter in the human brain: a PET study. European Journal of Nuclear Medicine and Molecular Imaging 2006, 33 (6) , 657-668. https://doi.org/10.1007/s00259-005-0027-9
    63. Sylvie Chalon, Hakan Hall, Wadad Saba, Lucette Garreau, Frédéric Dollé, Christer Halldin, Patrick Emond, Michel Bottlaender, Jean-Bernard Deloye, Julie Helfenbein, Jean-Claude Madelmont, Sylvie Bodard, Zoïa Mincheva, Jean-Claude Besnard, Denis Guilloteau. Pharmacological Characterization of (E)-N-(4-Fluorobut-2-enyl)-2β-carbomethoxy-3β-(4′-tolyl)nortropane (LBT-999) as a Highly Promising Fluorinated Ligand for the Dopamine Transporter. The Journal of Pharmacology and Experimental Therapeutics 2006, 317 (1) , 147-152. https://doi.org/10.1124/jpet.105.096792
    64. Frédéric Dollé, Patrick Emond, Sylvie Mavel, Stéphane Demphel, Françoise Hinnen, Zoïa Mincheva, Wadad Saba, Heric Valette, Sylvie Chalon, Christer Halldin, Julie Helfenbein, Joël Legaillard, Jean-Claude Madelmont, Jean-Bernard Deloye, Michel Bottlaender, Denis Guilloteau. Synthesis, radiosynthesis and in vivo preliminary evaluation of [11C]LBT-999, a selective radioligand for the visualisation of the dopamine transporter with PET. Bioorganic & Medicinal Chemistry 2006, 14 (4) , 1115-1125. https://doi.org/10.1016/j.bmc.2005.09.035
    65. Ming Chi Shih, Marcelo Queiroz Hoexter, Luiz Augusto Franco de Andrade, Rodrigo Affonseca Bressan. Parkinson’s disease and dopamine transporter neuroimaging: a critical review. Sao Paulo Medical Journal 2006, 124 (3) , 168-175. https://doi.org/10.1590/S1516-31802006000300014
    66. Jill B. Rhoden, Maud Bouvet, Sari Izenwasser, Dean Wade, Stacey A. Lomenzo, Mark L. Trudell. Structure–activity studies of 3′-4′-dichloro-meperidine analogues at dopamine and serotonin transporters. Bioorganic & Medicinal Chemistry 2005, 13 (19) , 5623-5634. https://doi.org/10.1016/j.bmc.2005.05.025
    67. Aurelija Jucaite, Elisabeth Fernell, Christer Halldin, Hans Forssberg, Lars Farde. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: Association between striatal dopamine markers and motor hyperactivity. Biological Psychiatry 2005, 57 (3) , 229-238. https://doi.org/10.1016/j.biopsych.2004.11.009
    68. Erkki Tupala, Jari Tiihonen. Dopamine and alcoholism: neurobiological basis of ethanol abuse. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2004, 28 (8) , 1221-1247. https://doi.org/10.1016/j.pnpbp.2004.06.022
    69. Fadi Masri, Françoise Riche, Andre Durif, Christian Philouze, Yannick Vallée. Synthesis of stereoisomers of 6β- and 7β-(benzylthio)-3-( p -tolyl) tropane-2-carboxylic acid methyl ester. Journal of Sulfur Chemistry 2004, 25 (4) , 259-268. https://doi.org/10.1080/17415990412331282459
    70. Elsa Diguet, Pierre‐Olivier Fernagut, Xing Wei, Yansheng Du, Richard Rouland, Christian Gross, Erwan Bezard, François Tison. Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease. European Journal of Neuroscience 2004, 19 (12) , 3266-3276. https://doi.org/10.1111/j.0953-816X.2004.03372.x
    71. Paola Piccini, Alan Whone. Functional brain imaging in the differential diagnosis of Parkinson's disease. The Lancet Neurology 2004, 3 (5) , 284-290. https://doi.org/10.1016/S1474-4422(04)00736-7
    72. Sylvie Mavel, Mohamed Abarbri, Yves Frangin, Alain Duchène, Patrick Emond. Fragmentation pathway of dopamine transporter ligands: N-substituted-2β-carbomethoxy-3β-phenylnortropane derivatives. Journal of Pharmaceutical and Biomedical Analysis 2004, 35 (1) , 193-198. https://doi.org/10.1016/j.jpba.2003.12.017
    73. Lifen Xu, Santosh S. Kulkarni, Sari Izenwasser, Jonathan L. Katz, Theresa Kopajtic, Stacey A. Lomenzo, Amy Hauck Newman, Mark L. Trudell. Synthesis and Monoamine Transporter Binding of 2-(Diarylmethoxymethyl)-3β-aryltropane Derivatives. Journal of Medicinal Chemistry 2004, 47 (7) , 1676-1682. https://doi.org/10.1021/jm030430a
    74. Erwan Bezard, Jerome Baufreton, Geraint Owens, Alan R. Crossman, Hank Dudek, Anne Taupignon, Jonathan M. Brotchie. Sonic hedgehog is a neuromodulator in the adult subthalamic nucleus. The FASEB Journal 2003, 17 (15) , 2337-2338. https://doi.org/10.1096/fj.03-0291fje
    75. Paola P. Piccini. Dopamine transporter: Basic aspects and neuroimaging. Movement Disorders 2003, 18 (S7) , S3-S8. https://doi.org/10.1002/mds.10571
    76. Erkki Tupala, Håkan Hall, Kim Bergström, Tuija Mantere, Pirkko Räsänen, Terttu Särkioja, Jari Tiihonen. Dopamine D 2 receptors and transporters in type 1 and 2 alcoholics measured with human whole hemisphere autoradiography. Human Brain Mapping 2003, 20 (2) , 91-102. https://doi.org/10.1002/hbm.10129
    77. Caroline Prunier, Erwan Bézard, Jérôme Montharu, Marina Mantzarides, Jean-Claude Besnard, Jean-Louis Baulieu, Christian Gross, Denis Guilloteau, Sylvie Chalon. Presymptomatic diagnosis of experimental Parkinsonism with 123I-PE2I SPECT. NeuroImage 2003, 19 (3) , 810-816. https://doi.org/10.1016/S1053-8119(03)00163-0
    78. Erkki Tupala, Håkan Hall, Kim Bergström, Tuija Mantere, Pirkko Räsänen, Terttu Särkioja, Jukka Hiltunen, Jari Tiihonen. Different effect of age on dopamine transporters in the dorsal and ventral striatum of controls and alcoholics. Synapse 2003, 48 (4) , 205-211. https://doi.org/10.1002/syn.10206
    79. Wassilios Meissner, Sandra Dovero, Bernard Bioulac, Christian E. Gross, Erwan Bezard. Compensatory regulation of striatal neuropeptide gene expression occurs before changes in metabolic activity of basal ganglia nuclei. Neurobiology of Disease 2003, 13 (1) , 46-54. https://doi.org/10.1016/S0969-9961(03)00011-1
    80. Jia Zhou, Ao Zhang, Thomas Kläss, Kenneth M. Johnson, Cheng Z. Wang, Yan Ping Ye, Alan P. Kozikowski. Biaryl Analogues of Conformationally Constrained Tricyclic Tropanes as Potent and Selective Norepinephrine Reuptake Inhibitors:  Synthesis and Evaluation of Their Uptake Inhibition at Monoamine Transporter Sites. Journal of Medicinal Chemistry 2003, 46 (10) , 1997-2007. https://doi.org/10.1021/jm020596w
    81. Christian E. Gross, Paula Ravenscroft, Sandra Dovero, Mohamed Jaber, Bernard Bioulac, Erwan Bezard. Pattern of levodopa‐induced striatal changes is different in normal and MPTP‐lesioned mice. Journal of Neurochemistry 2003, 84 (6) , 1246-1255. https://doi.org/10.1046/j.1471-4159.2003.01600.x
    82. Sylvie Chalon, Jari Tarkiainen, Lucette Garreau, Hakan Hall, Patrick Emond, Johnny Vercouillie, Lars Farde, Philippe Dasse, Katarina Varnas, Jean-Claude Besnard, Christer Halldin, Denis Guilloteau. Pharmacological Characterization of N,N-Dimethyl-2-(2-amino-4-methylphenyl thio)benzylamine as a Ligand of the Serotonin Transporter with High Affinity and Selectivity. The Journal of Pharmacology and Experimental Therapeutics 2003, 304 (1) , 81-87. https://doi.org/10.1124/jpet.102.042226
    83. Meixiang Yu, Anu J. Airaksinen, Antony D. Gee, Simo Lötjönen, Jyrki T. Kuikka, Jouko J. Vepsäläinen, Jukka Hiltunen, Kim A. Bergström. Radiosynthesis of [ 123 I] N ‐(3‐iodoprop‐(2 E )‐enyl)‐2α‐(imino‐methyl)‐3β‐(3′,4′‐dichlorophenyl) nortropane as a potential SPET tracer for dopamine transporter. Journal of Labelled Compounds and Radiopharmaceuticals 2002, 45 (12) , 1011-1017. https://doi.org/10.1002/jlcr.619
    84. E. Berthommier, C. Loc'h, S. Chalon, C. Olivier, P. Emond, H. Dao Boulanger, M.A. Lelait, L. Mauclaire. New preparation of [ 123 I]PE2I: investigation of the oxidation and purification steps. Journal of Labelled Compounds and Radiopharmaceuticals 2002, 45 (12) , 1019-1028. https://doi.org/10.1002/jlcr.620
    85. F. Turpin, F. Masri, F. Riché, E. Berthommier, P. Emond, M. Vidal, P. Auzeloux, C. Loc'h, N. Neuquelman, L. Mauclaire. Synthesis of two novel oxocyclam‐binding technetium complexes containing an analogue of cocaine. Journal of Labelled Compounds and Radiopharmaceuticals 2002, 45 (5) , 379-393. https://doi.org/10.1002/jlcr.560
    86. Lifen Xu, Sari Izenwasser, Jonathan L. Katz, Theresa Kopajtic, Cheryl Klein-Stevens, Naiju Zhu, Stacey A. Lomenzo, Leyte Winfield, Mark L. Trudell. Synthesis and Biological Evaluation of 2-Substituted 3β-Tolyltropane Derivatives at Dopamine, Serotonin, and Norepinephrine Transporters. Journal of Medicinal Chemistry 2002, 45 (6) , 1203-1210. https://doi.org/10.1021/jm010453u
    87. Guylène Page, Sylvie Chalon, Patrick Emond, Jean-Marie Maloteaux, Emmanuel Hermans. Pharmacological characterisation of (E)-N-(3-iodoprop-2-enyl)-2β-carbomethoxy-3β-(4′-methylphenyl)nortropane (PE2I) binding to the rat neuronal dopamine transporter expressed in COS cells. Neurochemistry International 2002, 40 (2) , 105-113. https://doi.org/10.1016/S0197-0186(01)00086-9
    88. Stéphanie Barc, Guylène Page, Laurence Barrier, Lucette Garreau, Denis Guilloteau, Bernard Fauconneau, Sylvie Chalon. Relevance of different striatal markers in assessment of the MPP + ‐induced dopaminergic nigrostriatal injury in rat. Journal of Neurochemistry 2002, 80 (3) , 365-374. https://doi.org/10.1046/j.0022-3042.2001.00743.x
    89. John L Neumeyer, Xiao-Hui Gu, L.Alexander van Vliet, Nicholas J DeNunzio, Daniela E Rusovici, Dana J Cohen, S.Stevens Negus, Nancy K Mello, Jean M Bidlack. Mixed κ agonists and μ agonists/Antagonists as potential pharmacotherapeutics for cocaine abuse: synthesis and opioid receptor binding affinity of N-substituted derivatives of morphinan. Bioorganic & Medicinal Chemistry Letters 2001, 11 (20) , 2735-2740. https://doi.org/10.1016/S0960-894X(01)00543-1
    90. S Thobois, S Guillouet, E Broussolle. Contributions of PET and SPECT to the understanding of the pathophysiology of Parkinson’s disease. Neurophysiologie Clinique/Clinical Neurophysiology 2001, 31 (5) , 321-340. https://doi.org/10.1016/S0987-7053(01)00273-8
    91. Erkki Tupala, Jyrki T. Kuikka, Håkan Hall, Kim Bergström, Terttu Särkioja, Pirkko Räsänen, Tuija Mantere, Jukka Hiltunen, Jouko Vepsäläinen, Jari Tiihonen. Measurement of the Striatal Dopamine Transporter Density and Heterogeneity in Type 1 Alcoholics Using Human Whole Hemisphere Autoradiography. NeuroImage 2001, 14 (1) , 87-94. https://doi.org/10.1006/nimg.2001.0793
    92. Patrick Emond, Julie Helfenbein, Sylvie Chalon, Lucette Garreau, Johnny Vercouillie, Yves Frangin, Jean Claude Besnard, Denis Guilloteau. Synthesis of Tropane and Nortropane Analogues with Phenyl Substitutions as Serotonin Transporter Ligands. Bioorganic & Medicinal Chemistry 2001, 9 (7) , 1849-1855. https://doi.org/10.1016/S0968-0896(01)00083-9
    93. Thomas Poyot, Françoise Condé, Marie-Claude Grégoire, Vincent Frouin, Christine Coulon, Chantal Fuseau, Françoise Hinnen, Frédéric Dollé, Philippe Hantraye, Michel Bottlaender. Anatomic and Biochemical Correlates of the Dopamine Transporter Ligand 11 C-PE2I in Normal and Parkinsonian Primates: Comparison with 6-[ 18 F]Fluoro-L-Dopa. Journal of Cerebral Blood Flow & Metabolism 2001, 21 (7) , 782-792. https://doi.org/10.1097/00004647-200107000-00003
    94. E Tupala, H Hall, K Bergström, T Särkioja, P Räsänen, T Mantere, J Callaway, J Hiltunen, J Tiihonen. Dopamine D2/D3-receptor and transporter densities in nucleus accumbens and amygdala of type 1 and 2 alcoholics. Molecular Psychiatry 2001, 6 (3) , 261-267. https://doi.org/10.1038/sj.mp.4000859
    95. E Bezard, T Boraud, S Chalon, J.M Brotchie, D Guilloteau, C.E Gross. Pallidal border cells: an anatomical and electrophysiological study in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkey. Neuroscience 2001, 103 (1) , 117-123. https://doi.org/10.1016/S0306-4522(00)00546-7
    96. Berend Olivier, Willem Soudijn, Ineke van Wijngaarden. Serotonin, dopamine and norepinephrine transporters in the central nervous system and their inhibitors. 2000, 59-119. https://doi.org/10.1007/978-3-0348-8391-7_3
    97. P. Fleuranceau-Morel, L. Barrier, B. Fauconneau, A. Piriou, F. Huguet. Origin of 4-hydroxynonenal incubation-induced inhibition of dopamine transporter and Na+/K+ adenosine triphosphate in rat striatal synaptosomes. Neuroscience Letters 1999, 277 (2) , 91-94. https://doi.org/10.1016/S0304-3940(99)00652-7
    98. J. Helfenbein, C. Loc'h, M. Bottlaender, P. Emond, C. Coulon, M Ottaviani, C. Fuseau, S. Chalon, I. Guenther, J-C. Besnard, Y. Frangin, D. Guilloteau, B. Maziere. A selective radiobrominated cocaine analogue for imaging of dopamine uptake sites: Pharmacological evaluation and pet experiments. Life Sciences 1999, 65 (25) , 2715-2726. https://doi.org/10.1016/S0024-3205(99)00540-8
    99. Sylvie Chalon, Lucette Garreau, Patrick Emond, Luc Zimmer, Marie-Paule Vilar, Jean-Claude Besnard, Denis Guilloteau. Pharmacological Characterization of (E)-N-(3-iodoprop-2-enyl)-2β-Carbomethoxy-3β-(4′-methylphenyl)nortropane as a Selective and Potent Inhibitor of the Neuronal Dopamine Transporter. The Journal of Pharmacology and Experimental Therapeutics 1999, 291 (2) , 648-654. https://doi.org/10.1016/S0022-3565(24)35151-1
    100. Anu J. Airaksinen, Kari A. Tuppurainen, Simo E. Lötjönen, Matthias Niemitz, Meixiang Yu, Jouko J. Vepsäläinen, Reino Laatikainen, Jukka Hiltunen, Kim A. Bergström. Nuclear magnetic resonance and molecular orbital study of some cocaine analogues. Tetrahedron 1999, 55 (34) , 10537-10546. https://doi.org/10.1016/S0040-4020(99)00577-3
    Load all citations
    Download PDF
    Go to Journal of Medicinal Chemistry
    Get e-Alerts
    Get e-Alerts

    Journal of Medicinal Chemistry

    Cite this: J. Med. Chem. 1997, 40, 9, 1366–1372
    Click to copy citationCitation copied!
    https://doi.org/10.1021/jm960795d
    Published April 25, 1997
    Copyright © 1997 American Chemical Society
    Request reuse permissions

    Article Views

    752

    Altmetric

    -

    Citations

    112
    Learn about these metrics

    Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.

    Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.

    The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated.